glp-1 nasal ring Glp 1 New nasal spray may stop rapid heart rhythm The most bizarre side effects

India GLP-1 Receptor Agonist Market Analysis The India GLP-1 receptor agonist market was valued at USD 1.20 billion in 2025, fueled by expanding contract peptide manufacturing ecosystem, increasing participation of domestic pharmaceutical companies in GLP-1 biosimilar and novel peptide development, and rising availability of specialized diabetes clinics in urban centers

Non-injectable treatment formats are becoming a strategic entry point for wider patient adoption, particularly for patients who are hesitant to start injectable GLP-1 therapies or may struggle with long-term injection adherence, storage requirements, and administration fatigue

The study employed a double-blinded design, with participants receiving a daily dose of 120mg HRS-7535 for a period of 12 weeks

Pain and suffering compensation is designed to provide a financial remedy for these personal losses

But the FDA did not take a stance against compounders, instead acknowledging the publics use of these unapproved pharmacy-created medicines

Wegovy works by mimicking the naturally occurring glucagon-like peptide-1 (GLP-1) hormone, which regulates appetite and metabolism